Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

About KAMRAB® KAMRAB is a human rabies immune globulin (HRIG) indicated for passive, transient post-exposure prophylaxis (PEP) of rabies infection to persons of all ages when given immediately after ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...

“The discovery that memory B cells and antibodies specific to [Nipah] persist 20 years post-infection suggests that vaccines ...

A smaller proportion of women vs. men underwent lung transplantation, plus women spent a longer time on the wait list before ...

Avian influenza, commonly termed “bird flu”, is caused by the avian influenza virus A. This virus is usually found in wild ...

In a recent study, scientists have introduced an innovative imaging technique that provides an unparalleled view of the bone ...

Nano-sized, tumor-targeting particles induced self-destruction of cancer cells in preclinical studies. A new twist on a ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...